Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher’s N.C. production facility
Vaxcyte is paying Thermo Fisher Scientific up to $1 billion to access vaccine fill-finish capacity at the CDMO’s production facility in Greenville, North Carolina. Vaxcyte positioned the deal as a “long-term U.S.
